State Of New Jersey Common Pension Fund D Allakos Inc. Transaction History

State Of New Jersey Common Pension Fund D

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$5.08 - $9.81 $178,572 - $344,841	-35,152 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$8.55 - $111.89 $7,977 - $104,393	933 Added 2.73%	35,152 $344,000
Q3 2021 Oct 27, 2021	BUY	$76.53 - $110.43 $735,759 - $1.06 Million	9,614 Added 39.07%	34,219 $3.62 Million
Q2 2021 Jul 23, 2021	BUY	$85.37 - $114.1 $616,456 - $823,916	7,221 Added 41.54%	24,605 $2.1 Million
Q1 2021 Apr 27, 2021	SELL	$109.73 - $153.66 $993,714 - $1.39 Million	-9,056 Reduced 34.25%	17,384 $2 Million
Q4 2020 Feb 03, 2021	BUY	$79.58 - $152.45 $71,383 - $136,747	897 Added 3.51%	26,440 $3.7 Million
Q3 2020 Oct 27, 2020	SELL	$66.43 - $90.99 $139,237 - $190,715	-2,096 Reduced 7.58%	25,543 $2.08 Million
Q2 2020 Aug 04, 2020	BUY	$44.04 - $80.69 $1.22 Million - $2.23 Million	27,639 New	27,639 $1.99 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.